MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Avalanche Biotechnologies Company Profile (NASDAQ:AAVL)

Consensus Ratings for Avalanche Biotechnologies (NASDAQ:AAVL) (?)
Ratings Breakdown: 3 Hold Rating(s), 3 Buy Rating(s)
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $37.42 (154.19% upside)

Analysts' Ratings History for Avalanche Biotechnologies (NASDAQ:AAVL)
Show:
DateFirmActionRatingPrice TargetActions
7/27/2015Chardan CapitalReiterated RatingNeutral$17.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/23/2015Chardan CapitalUpgradeSell -> Neutral$20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/17/2015Piper JaffrayReiterated RatingOverweight$52.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/17/2015Cowen and CompanyReiterated RatingOutperform$55.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/17/2015SunTrustLower Price TargetBuy -> Neutral$60.00 -> $25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/16/2015Chardan CapitalDowngradeNeutral -> Sell$40.00 -> $20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/16/2015SunTrustDowngradeBuy -> Neutral$60.00 -> $25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/16/2015Jefferies GroupReiterated RatingBuy$51.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/16/2015William BlairDowngradeOutperform -> Market Perform$53.00 -> $24.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/3/2015Piper JaffrayReiterated RatingOverweight$52.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/23/2015Jefferies GroupReiterated RatingBuy$51.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/15/2015Piper JaffrayReiterated RatingOverweight$52.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/26/2015Jefferies GroupBoost Price TargetBuy$46.00 -> $51.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/26/2015Chardan CapitalReiterated RatingHold$40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/26/2015Piper JaffrayBoost Price TargetOverweight$52.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/9/2015SunTrustInitiated CoverageBuy$60.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/9/2015Piper JaffrayReiterated RatingOverweight$47.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/19/2015Chardan CapitalInitiated CoverageNeutral$40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/13/2015Jefferies GroupBoost Price TargetBuy$40.00 -> $46.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/2/2014Piper JaffrayBoost Price Target$47.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/25/2014William BlairInitiated CoverageOutperform$52.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/25/2014Cowen and CompanyInitiated CoverageOutperform$45.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/25/2014Piper JaffrayInitiated CoverageOverweight$39.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/25/2014Jefferies GroupInitiated CoverageBuy$40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 8/1/2013 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha